Unlikely to cause harm — often a labeling or packaging issue.
Defective container: potential for non-sealed pouches which can lead to product leakage.
| Brand name | PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID |
| Generic name | PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID |
| Distributed by / for | Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 |
| NDC | 0093-3560-26 |
| Full product label | PEG-3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate, and Ascorbic Acid for Oral Solution 100g/7.5 g /2.691 g/1.015 g/ 5.9 g / 4.7 g, 3 pouches/carton, Rx only, Distributed by: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC# 0093-3560-26. |
| Recalling firm | Novel Laboratories, Inc. d.b.a Lupin Somerset |
| Distribution | Nationwide in the US. |
| Quantity | 13,200 cartons |
| Recall initiated | 2024-07-02 |
| Report date | 2024-08-14 |
| Recall completed | 2025-04-28 |
| Recall number | D-0628-2024 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Somerset NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗